dose and schedule depend on the protocol and clinicians plan
The FDA has issued a warning about serious safety risks linked to unapproved and compounded versions of GLP-1 receptor agonists, including semaglutide (the active ingredient in Ozempic and Wegovy)
In addition, epigenetic mechanisms may mediate interactions between genetic variations and taste receptor expression
3 In April 2026, Health Canada authorized a generic semaglutide injection, which is a useful reminder that an approved synthetic peptide medicine is very different from an unauthorized compounded or online product
To learn more about how medical weight loss works and how it can improve your health, call Enlift Health Medical Clinic or request an appointment online today
However, the existence of these products reflects genuine scientific interest in alternative delivery routes for triple-agonist peptides